These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 12845673)
1. Active stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinase. Fromigué O; Louis K; Wu E; Belhacène N; Loubat A; Shipp M; Auberger P; Mari B Int J Cancer; 2003 Sep; 106(3):355-63. PubMed ID: 12845673 [TBL] [Abstract][Full Text] [Related]
2. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol-3-kinase-Akt kinase and p42/p44 mitogen-activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of amyloid precursor protein. Cheng G; Yu Z; Zhou D; Mattson MP Exp Neurol; 2002 Jun; 175(2):407-14. PubMed ID: 12061870 [TBL] [Abstract][Full Text] [Related]
4. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells. Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401 [TBL] [Abstract][Full Text] [Related]
5. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. Choi YA; Lim HK; Kim JR; Lee CH; Kim YJ; Kang SS; Baek SH J Biol Chem; 2004 Aug; 279(35):36579-85. PubMed ID: 15220345 [TBL] [Abstract][Full Text] [Related]
6. The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro. Lövdahl C; Thyberg J; Hultgârdh-Nilsson A J Vasc Res; 2000; 37(5):345-54. PubMed ID: 11025397 [TBL] [Abstract][Full Text] [Related]
7. Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways. Akimoto T; Nonaka T; Ishikawa H; Sakurai H; Saitoh JI; Takahashi T; Mitsuhashi N Int J Radiat Oncol Biol Phys; 2001 May; 50(1):195-201. PubMed ID: 11316564 [TBL] [Abstract][Full Text] [Related]
8. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue. Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032 [TBL] [Abstract][Full Text] [Related]
9. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Knockaert M; Lenormand P; Gray N; Schultz P; Pouysségur J; Meijer L Oncogene; 2002 Sep; 21(42):6413-24. PubMed ID: 12226745 [TBL] [Abstract][Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034 [TBL] [Abstract][Full Text] [Related]
12. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt. Conant K; St Hillaire C; Nagase H; Visse R; Gary D; Haughey N; Anderson C; Turchan J; Nath A J Biol Chem; 2004 Feb; 279(9):8056-62. PubMed ID: 14679206 [TBL] [Abstract][Full Text] [Related]
14. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK. Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375 [TBL] [Abstract][Full Text] [Related]
15. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway. Kakazu A; Chandrasekher G; Bazan HE Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3485-92. PubMed ID: 15452053 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells. Zagozdzon R; Bougeret C; Fu Y; Avraham HK Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987 [TBL] [Abstract][Full Text] [Related]
17. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330 [TBL] [Abstract][Full Text] [Related]
18. nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1. Tejedo JR; Cahuana GM; Ramírez R; Esbert M; Jiménez J; Sobrino F; Bedoya FJ Endocrinology; 2004 May; 145(5):2319-27. PubMed ID: 14764634 [TBL] [Abstract][Full Text] [Related]
19. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Pi X; Yan C; Berk BC Circ Res; 2004 Feb; 94(3):362-9. PubMed ID: 14670836 [TBL] [Abstract][Full Text] [Related]
20. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Noël A; Boulay A; Kebers F; Kannan R; Hajitou A; Calberg-Bacq CM; Basset P; Rio MC; Foidart JM Oncogene; 2000 Mar; 19(12):1605-12. PubMed ID: 10734321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]